市場調査レポート

商品コード

1593466

遺伝子パネルの市場規模、シェア、成長分析、製品・サービス別、手法別、デザイン別、地域別 - 産業予測、2024年～2031年

Gene Panel Market Size, Share, Growth Analysis, By Product and Services, By Technique, By Design, By Region - Industry Forecast 2024-2031

出版日: 2024年11月12日
発行: SkyQuest
ページ情報: 英文 214 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

遺伝子パネルの世界市場規模は2022年に24億米ドルと評価され、2023年の28億6,000万米ドルから2031年には117億5,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは19.30%で成長する見込みです。

個別化医療と遺伝子技術の急速な進歩が、世界の遺伝子パネル市場の成長を大きく促進しています。ゲノム配列決定コストが低下するにつれて、遺伝子パネルはますます手頃な価格となり、幅広い疾患に対する包括的な遺伝子検査・解析が可能となっています。遺伝性疾患の有病率の上昇と、正確でテーラーメードの治療戦略に対する需要の高まりが、この市場拡大に拍車をかけています。遺伝子パネルは、遺伝的素因と潜在的な治療経路に関する重要な洞察を提供し、研究、診断、治療開発への応用を強化します。これらのパネルは、様々な疾患に関連する遺伝的変異を検出するために一括して解析された遺伝子のキュレーションコレクションで構成されており、複数の遺伝子を同時に効率的かつ的を絞って調べることができます。この機能は、遺伝性疾患を解明するだけでなく、オーダーメイドの治療計画の作成も促進します。遺伝子パネルの将来は、その精度を高め、臨床的有用性を広げると期待されるバイオインフォマティクスとシーケンシング技術における継続的な技術革新によって後押しされ、有望視されています。遺伝子パネルが標準的な臨床診療にますます組み込まれ、治療と予防の両面で利用が拡大するにつれて、個別化医療の領域におけるその重要性は増大し続け、ヘルスケア部門における開発と応用の大きな機会がもたらされるであろう。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東およびアフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Qiagen
Roche
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Becton, Dickinson and Company（BD）
Sangamo Therapeutics

Product Code: SQMIG35H2314

Global Gene Panel Market size was valued at USD 2.40 Billion in 2022 poised to grow from USD 2.86 Billion in 2023 to USD 11.75 Billion by 2031, growing at a CAGR of 19.30% in the forecast period (2024-2031).

The rapid advancements in personalized medicine and genetic technologies are significantly driving the growth of the global gene panel market. As genomic sequencing costs decline, gene panels have become increasingly affordable, enabling comprehensive genetic testing and analysis for a wide range of diseases. The rising prevalence of hereditary conditions and the growing demand for precise, tailored treatment strategies fuel this market expansion. Gene panels provide critical insights into genetic predispositions and potential treatment pathways, enhancing their application in research, diagnostics, and therapeutic development. These panels consist of a curated collection of genes analyzed collectively to detect genetic variations associated with various disorders, allowing for efficient and targeted investigations of multiple genes simultaneously. This capability not only elucidates hereditary diseases but also fosters the creation of customized treatment plans. The future of gene panels appears promising, bolstered by ongoing innovations in bioinformatics and sequencing technologies that are expected to enhance their accuracy and broaden their clinical utility. As gene panels become increasingly integrated into standard clinical practice and expand their use in both therapeutic and preventive contexts, their significance in the realm of personalized medicine will continue to grow, presenting vast opportunities for development and application in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Panel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Panel Market Segmental Analysis

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Gene Panel Market

The global gene panel market is significantly propelled by advancements in next-generation sequencing (NGS) technologies, which enhance precision, speed, and cost-efficiency in genetic analyses. These innovations facilitate comprehensive genomic profiling, thereby enabling personalized medicine tailored to individual genetic profiles. As healthcare increasingly shifts towards targeted therapies and precision diagnostics, the demand for gene panels in both clinical and research settings is rising sharply. Additionally, the ability of NGS to process large amounts of genetic information quickly allows for more effective disease diagnosis and treatment plans, further fueling market growth and attracting investments in genetic research and healthcare innovations.

Restraints in the Global Gene Panel Market

A significant restraint for the global gene panel market is the limited knowledge and understanding among healthcare professionals and patients regarding gene panel testing. Many individuals may not be aware of the advantages and applications of DNA panels, which can hinder their willingness to pursue genetic testing. This lack of education can result in skepticism or misconceptions about the value and utility of gene panels, ultimately slowing down adoption rates. Consequently, the limited awareness diminishes the perceived benefits of genetic testing, thus affecting market expansion and stifling the potential advancements that gene panel technology could offer in personalized medicine and tailored healthcare solutions.

Market Trends of the Global Gene Panel Market

The global gene panel market is experiencing significant growth driven by a marked surge in the adoption of personalized medicine. As healthcare practitioners increasingly leverage gene panels for tailored treatment regimens, this trend emphasizes the importance of precision diagnostics and targeted therapies. Advancements in genomics, particularly in next-generation sequencing technologies, have played a pivotal role in enhancing the accuracy and efficiency of genetic testing, enabling clinicians to make more informed decisions about patient care. Consequently, this shift towards personalized healthcare is not only improving patient health outcomes but also catalyzing demand for innovative gene panel products, positioning the market for substantial expansion.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Pricing Analysis

Global Gene Panel Market Size by Product and Service & CAGR (2024-2031)

Test Kits
Testing Services

Global Gene Panel Market Size by Technique & CAGR (2024-2031)

Amplicon-based Approach
Hybridization-based Approach

Global Gene Panel Market Size byDesign & CAGR (2024-2031)

Predesigned Gene Panel
Customized Gene Panel

Global Gene Panel Market Size byApplication & CAGR (2024-2031)

Cancer Risk Assessment
- Syndrome-specific
- High-penetrance
- High and Moderate-penetrance
- Comprehensive Cancer Risk
Diagnosis of Congenital Diseases
Pharmacogenetics
Other Applications

Global Gene Panel Market Size by End-use & CAGR (2024-2031)

Research and Academic Institutes
Hospital and Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies

Global Gene Panel Market Size & CAGR (2024-2031)

North America, (Product and Services, Technique, Design, Application, End User)
- US
- Canada
Europe, (Product and Services, Technique, Design, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product and Services, Technique, Design, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product and Services, Technique, Design, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product and Services, Technique, Design, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangamo Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates

遺伝子パネルの市場規模、シェア、成長分析、製品・サービス別、手法別、デザイン別、地域別 - 産業予測、2024年～2031年

Gene Panel Market Size, Share, Growth Analysis, By Product and Services, By Technique, By Design, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

遺伝子パネル市場：製品・サービス別

遺伝子パネル市場：手法別

遺伝子パネル市場：デザイン別

遺伝子パネル市場：用途別

遺伝子パネル市場：最終用途別

遺伝子パネル市場規模：地域別